Literature DB >> 16098483

Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1.

Harumasa Ueo1, Hideyuki Motohashi, Toshiya Katsura, Ken-ichi Inui.   

Abstract

We examined the substrate specificity of human organic anion transporter (hOAT) 1 and hOAT3 for various cephalosporin antibiotics, cephaloridine, cefdinir, cefotiam, ceftibuten, cefaclor, ceftizoxime, cefoselis and cefazolin by using HEK293 cells stably transfected with hOAT1 or hOAT3 cDNA (HEK-hOAT1, HEK-hOAT3). Additionally, we examined the uptake of various compounds by these transfectants. The mRNA level of hOAT3 in HEK-hOAT3 was about three-fold that of hOAT1 in HEK-hOAT1. Functional expression of hOAT1 and hOAT3 was confirmed by the uptake of p-[14C]aminohippurate and [3H]estrone sulfate, respectively. p-[14C]Aminohippurate, [3H]estrone sulfate, [14C]captopril, [3H]methotrexate, [3H]ochratoxin A, [3H]leucovorin and [3H]cimetidine were shown to be substrates for hOAT1 and hOAT3, and [3H]dehydroepiandrosterone sulfate was shown to be a substrate for hOAT3. All cephalosporin anitibiotics tested were shown to inhibit the uptake of p-[14C]aminohippurate and [3H]estrone sulfate via hOAT1 and hOAT3, respectively, in a dose-dependent manner, and the IC50 values of these antibiotics, except for cefaclor, for the hOAT1-mediated uptake of p-[14C]aminohippurate were within four-fold of those for the hOAT3-mediated uptake of [3H]estrone sulfate. The uptake of cephaloridine, cefdinir and cefotiam by HEK-hOAT3 was 35-50-fold greater than that by control cells. Moreover, the accumulation of the other cephalolsporin antibiotics was significantly greater in HEK-hOAT3 than in control cells. In contrast, the uptake of these antibiotics by HEK-hOAT1 was within two-fold of that by control cells. In conclusion, hOAT3 plays a more important role than hOAT1 in the renal secretion of cephalosporin antibiotics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16098483     DOI: 10.1016/j.bcp.2005.06.024

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  24 in total

1.  Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS).

Authors:  Manthena V Varma; Stefanus J Steyn; Charlotte Allerton; Ayman F El-Kattan
Journal:  Pharm Res       Date:  2015-07-09       Impact factor: 4.200

Review 2.  The organic anion transporter (OAT) family: a systems biology perspective.

Authors:  Sanjay K Nigam; Kevin T Bush; Gleb Martovetsky; Sun-Young Ahn; Henry C Liu; Erin Richard; Vibha Bhatnagar; Wei Wu
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

Review 3.  Choroid Plexus and Drug Removal Mechanisms.

Authors:  Austin Sun; Joanne Wang
Journal:  AAPS J       Date:  2021-05-03       Impact factor: 4.009

Review 4.  Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney.

Authors:  Hideyuki Motohashi; Ken-ichi Inui
Journal:  AAPS J       Date:  2013-02-22       Impact factor: 4.009

5.  Pharmacokinetics and pharmacogenomics of β-lactam-induced neutropenia.

Authors:  Andrea Hahn; Tsuyoshi Fukuda; David Hahn; Tomoyuki Mizuno; Robert W Frenck; Alexander A Vinks
Journal:  Pharmacogenomics       Date:  2016-04-05       Impact factor: 2.533

Review 6.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

7.  Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2).

Authors:  Yuichi Uwai; Hiroki Ida; Yoshie Tsuji; Toshiya Katsura; Ken-Ichi Inui
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

8.  Pharmacokinetic significance of renal OAT3 (SLC22A8) for anionic drug elimination in patients with mesangial proliferative glomerulonephritis.

Authors:  Yuji Sakurai; Hideyuki Motohashi; Ken Ogasawara; Tomohiro Terada; Satohiro Masuda; Toshiya Katsura; Noriko Mori; Motokazu Matsuura; Toshio Doi; Atsushi Fukatsu; Ken-ichi Inui
Journal:  Pharm Res       Date:  2005-11-01       Impact factor: 4.200

9.  Quantitative structure activity relationship for inhibition of human organic cation/carnitine transporter.

Authors:  Lei Diao; Sean Ekins; James E Polli
Journal:  Mol Pharm       Date:  2010-09-29       Impact factor: 4.939

10.  Relevance of PepT1 in the intestinal permeability and oral absorption of cefadroxil.

Authors:  Maria M Posada; David E Smith
Journal:  Pharm Res       Date:  2012-12-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.